Reduced glucosuria by oral magnesium supplementation and decreased lipid peroxidation by increased vitamin E supply in obese Zucker rats

Magnesium - Bulletin

Volumn 19, Issue 3, 1997, Pages 81-91

  Vormann, J ^a   Blumenthal, A ^a   Merker, H J ^a   Gunther T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744436710     PISSN: 0172908X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Takaya, K.; Ogawa, Y.; Isse, N.; Okazaki, T.; Satoh, N.; Masuzaki, H.; Mori, K.; Tamura, N.; Hosoda, K.; Nakao, K.: Molecular cloning of rat leptin receptor isoform complementary DNAs-Identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem. Biophys. Res. Comm. 225 (1996) 75-83.
2. Bray, G. A.: The Zucker-fatty rat: a review. Fed. Proc. 36 (1977) 148-153.
3. Schrezenmeir, J.: Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome. Experientia 52 (1996) 426-432.
4. Garland, H. O.: New experimental data on the relationship between diabetes mellitus and magnesium. Magnes. Res. 5 (1992) 193-202.
5. Nadler, J. L.; Buchanan, T.; Natarajan, R.; Antonipillai, I.; Bergman, R.; Rude, R.: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 21 (1993) 1024-1029.
6. Paolisso, G.; Scheen, A.; Cozzolino, D.; Di Maro, G.; Varricchio, M.; D'Onofrio, F.; Lefebvre, P. J.: Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J. Clin. Endocrin. Metab. 78 (1994) 1510-1514.
7. Gullestad, L.; Jacobsen, T.; Dolva, L. O.: Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care 17 (1994) 460-461.
8. Colditz, G. A.; Manson, J. E.; Stampfer, M. J.; Rosner, B.; Willett, W. C.; Speizer, F. E.: Diet and risk of clinical diabetes in women. Am. J. Clin. Nutr. 55 (1992) 1018-1023.
9. Mazur, A.; Gueux, E.; Rémésy, C.; Demigné, C.; Rayssiguier, Y.: Plasma and red blood cell magnesium concentrations in Zucker rats: influence of a high fibre diet. Magnes. Res. 2 (1989) 189-192.
10. Balon, T. W.; Gu, J. L.; Tokuyama, Y.; Jasman, A. P.; Nadler, J. L.: Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am. J. Physiol. 269 (1995) E745-E752.
11. Paolisso, G.; Guigliano, D.: Oxidative stress and insulin action: is there a relationship? Diabetologia 39 (1996) 357-363.
12. Baynes, J. W.: Role of oxidative stress in the development of complications in diabetes mellitus. Diabetes 40 (1991) 405-412.
13. Wiseman, H.: Dietary influences on membrane function: Importance in protection against oxidative damage and disease. J. Nutr. Biochem. 7 (1996) 2-15.
14. Wagner, B. A.; Buettner, G. R. Burns, C. P.: Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells. Arch. Biochem. Biophys 334 (1996) 261-267.
15. Burton, G. W.; Traber, M. G.: Vitamin E: Antioxidant, activity, biokinetics and bioavailability. Annu. Rev. Nutr. 10 (1990): 357-382.
16. Liebler, D. C.: The role of metabolism in the antioxidant function of vitamin E. Critic. Rev. Toxicol. 23 (1993) 147-169.
17. Paolisso, G.; D'Amore, A.; Guigliano, D.; Ceriello, A.; Varricchio, M.; D'Onofrio, F.: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am. J. Clin. Nutr. 57 (1993) 650-656.
18. Beales, B. E.; Williams, A. J. K.; Albertini, M. C.; Pozzilli, P.: Vitamin E delays diabetes onset in the non-obese diabetic mouse. Horm. Metab. Res. 26 (1994) 450-452.
19. Cordell, J. L.; Falini, B.; Erber, W. N.; Ghosh, A. K.; Abdulaziz, Z.; Macdonald, S.; Pulford, K. A. F.; Stein, H.; Mason, D. Y.: Immunoenzymatic labeling of monoclonal antibodies using immun complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32 (1984) 219-229.
20. Taylor, S. L.; Lamden, M. P.; Tappel, A. L.: Sensitive fluorimetric method for tissue tocopherol analysis. Lipids 11 (1976) 530-538.
21. Britton, R. S.; O'Neill, T.; Bacon, B. R.: Hepatic mitochondria malondialdehyde metabolism in rats with chronic iron overload. Hepatology 11 (1990) 93-97.
22. Gutteridge, J. M. C.; Tickner, T. R.: The characterization of thiobarbituric acid reactivity in human plasma and urine. Analyt. Biochem. 91 (1978) 250-257.
23. Hirose, H.; Lee, Y. H.; Inman, L. R.; Nagasawa, Y.; Johnson, J. H.; Unger, R. H.: Defective fatty-acid-mediated β-cell compensation in Zucker diabetic fatty rats. J. Biol. Chem. 271 (1996) 5633-5637.
24. Unger, R. H.; Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes 44 (1995) 863-870.
25. Taylor, S. L.; Lilly Lecture: Molecular mechanism of inslin resistance. Lessons from patients with mutations in the insulin receptor. Diabetes 41 (1992) 1473-1490.
26. Resnick, L. M.; Altura, B. T.; Gupta, R. K.; Laragh, J. H.; Alderman, M. H.; Altura, B. M.: Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 767-770.
27. Paolisso, G.; Ravussin, E.: Intracellular magnesium and insulin resistance: results in Pima indians and caucasians. J. Clin. Endocrin. Metab. 80 (1995) 1382-1385.
28. Paolisso, G.; Scheen, A.; D'Onofrio; Lefebvre, P.: Magnesium and glucose homeostasis. Diabetologia 33 (1990) 511-514.
29. Sjöholm, A.: Diabetes mellitus and impaired pancreatic β-cell proliferation. J. Int. Med. 239 (1996) 211-220.
30. Berggren, P.-O.; Bergsten, P.; Gylfe, E.; Larsson, R.; Hellman, B.: Interactions between magnesium and calcium in β-cell-rich pancreatic islets. Am. J. Physiol. 244 (1983) E541-E547.
31. Suarez, A.; Pulido, N.; Casla, A.; Casanova, B.; Arrieta, F. J.; Rovira, A.: Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia 38 (1995) 1262-1270.
32. Douillett, C.; Ciavatti, M.: Effect of vitamin E treatment on tissue fatty acids and cholesterol content in experimental diabetes. J. Nutr. Biochem. 6 (1995) 319-326.
33. Lowney, P.; Hannon, T. S.; Baron, A. D.: Magnesium deficiency enhances basal glucose disposal in the rat. Am. J. Physiol. 268 (1995) E925-E931.
34. Weglicki, W. B.; Phillips, T. M.; Freedman, A. M.; Cassidy, M. M.; Dickens, B. F.: Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Molec. Cell. Biochem. 110 (1992) 169-173.
35. Hotamisligil, G. S.; Shargill, N. S.; Spiegelman, B. M.: Adipose Expression of Tumor Necrosis Factor-α: Direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91.
36. Hotamisligil, G. S.; Johnson, R. S.; Distel, R. J.; Ellis, R.; Papaionnou, V. E.; Spiegelmann, B. M.: Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 (1996) 1377-1379.
37. Spence, L. A.; Mason, A. C.: Effects of magnesium supplementation on glucose and lipid control in the zucker fatty diabetic rat, a model of NIDDM. FASEB J., 11 (1997) A156.
38. 2+ channel activity. Am. J. Physiol. 270 E133-140.
39. Günther, T.; Höllriegl, V.; Vormann, J.; Bubeck, J.; Classen, H.-G.: Increased lipid peroxidation in rat tissues by magnesium deficiency and vitamin E depletion. Mg.-Bull. 16 (1994) 38-43.
40. Signorini, C.; Ferrali, M.; Ciccoli, L.; Sugherini, L.; Magnani, A.; Comporti, M.: Iron release, membrane protein oxidation and erythrocyte ageing. FEBS Lett. 362 (1995) 165-170.
41. Reif, D. W.; Schubert, J.; Aust, S. D.: Iron release from ferritin and lipid peroxidation by radiolytically generated reducing radicals. Arch. Biochem. Biophys. 264 (1988) 238-243.